Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate.
about
Mechanisms of arterial calcifications and consequences for cardiovascular functionMICS, an easily ignored contributor to arterial calcification in CKD patients.Speckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD.Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification.Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium dietRisk factors of one year increment of coronary calcifications and survival in hemodialysis patientsAssociation of osteocalcin and abdominal aortic calcification in older women: the study of osteoporotic fracturesEffect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.Vascular effects of bisphosphonates-a systematic review.Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification.Effect of medial calcification on vascular function in uremia.Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification.Mechanisms linking osteoporosis with cardiovascular calcification.Mechanisms and clinical consequences of vascular calcificationClinical, cellular, and molecular aspects of arterial calcification.A rat model of chronic kidney disease-mineral bone disorder.Mineralization by inhibitor exclusion: the calcification of collagen with fetuin.Phosphate: an old bone molecule but new cardiovascular risk factor.Alendronate as an effective treatment for bone loss and vascular calcification in kidney transplant recipients.The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients.Can bisphosphonates play a role in the treatment of children with chronic kidney disease?Parathyroid gland regulation: contribution of the in vivo and in vitro models.The realm of vitamin K dependent proteins: shifting from coagulation toward calcification.Treatment with pyrophosphate inhibits uremic vascular calcification.What Animal Models Have Taught Us About the Safety and Efficacy of Bisphosphonates in Chronic Kidney Disease.Lanthanum carbonate prevents accelerated medial calcification in uremic rats: role of osteoclast-like activity.Zoledronate inhibits phosphate and bone morphogenetic protein 2-induced extracellular calcification of vascular smooth muscle cells in vitro.Dietary L-lysine prevents arterial calcification in adenine-induced uremic rats.Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies.Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats.Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease.Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism.Chronic kidney disease induced by adenine: a suitable model of growth retardation in uremia.MicroRNA-34b/c inhibits aldosterone-induced vascular smooth muscle cell calcification via a SATB2/Runx2 pathway.Can Intestinal Phosphate Binding or Inhibition of Hydroxyapatite Growth in the Vascular Wall Halt the Progression of Established Aortic Calcification in Chronic Kidney Disease?Dietary phosphate modifies lifespan in Drosophila.Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.Nontraditional Cardiovascular Biomarkers and Risk Factors: Rationale and Future Perspectives.
P2860
Q26821993-C255B216-DF01-4187-BAD1-ADBDB749A61FQ30249410-8818F3D8-65C8-4062-8B38-ED78F6DE17BCQ30401905-F0D3C473-9E11-4850-959B-51518BC9A2B9Q30474772-E2F3BFAB-23A6-4870-B852-CBCA9B46C9C3Q33568884-6672A167-6150-467B-9E7B-9E97370C5B42Q33611410-FABF5BFF-D788-4490-8982-C40B61AA84A7Q33674200-4E5DA992-A8F8-49D0-AFCC-32DA6C08DC22Q34393174-882DD782-4BC6-42EF-A28F-340FA2AC6A78Q34468751-EFB513AE-7FDB-4E3B-9238-8B859B92F496Q35071037-2E07AE89-660E-40C2-9623-9DEE9CAD244EQ35086956-7B65AF3D-3E1E-41BA-B42D-5124075046D5Q35309274-EFAF3FDA-BA4A-43FE-AADC-B2FBCAA1863DQ35575965-96384228-670D-4FA2-BED7-60A93FFF9056Q36142207-D622B1C1-D1E1-456D-A6C9-2F032B63C9AEQ36837874-B5F4C647-42F0-4E42-8455-24334DB9CDE8Q37276108-50C73E57-282D-4F44-8A88-3AD7FF69FB1CQ37285120-131B9FEC-33AE-416C-A1B3-8B8431CA3CC5Q37492019-0D0B851C-8B2E-494F-8741-CFE698026ED4Q37622392-438DDD11-3B99-4740-A6F5-266EC93154E1Q37670856-5E5678F6-5324-47AE-BD8A-2F51122FEB0FQ37832414-3EF31051-86E9-43BA-8324-13610D45EE62Q38028534-9C3B1C90-5850-4D4C-AFFE-72AB650877FFQ38199459-92D60B3B-0E31-4242-8A9B-EB520079DDA8Q38599585-BBC0BEA6-73BC-4487-9D03-D34D5E878613Q38825566-3E22713E-3ECA-499D-91F1-3F3809A96526Q41846974-931BA3EB-5BF8-4C13-A2CA-428C58A62A65Q41935702-9F9BD9EA-95CF-4F00-8C80-57B7493C4BC0Q42545282-4502687D-B87B-43BA-92E9-C78BA6C0BF16Q44657342-498A799D-34B3-42D4-876E-DA4B3486696FQ46162426-FCDDD3C4-DBF4-48B3-A105-72D273AEBB0EQ46288096-FC140A25-35DD-4112-83F3-42C99C1D71E6Q50077724-965F24E2-2D4D-48FD-A20D-601D85A4D415Q51025105-37A88D2F-7789-46EB-B3B3-7539B3B6844EQ51583712-9FC075A6-8F00-4756-9C81-05AADDFB5E7FQ51614592-2B809CAF-E094-4237-A3F3-863DDC936FB2Q52743002-3F89097C-4F9A-4267-ACB2-D25CB38076D5Q53667873-B11FA3FE-B23A-4291-AA8B-F0010C488AD4Q55384368-6162AE47-7465-4108-8C3A-B09D816DD734
P2860
Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Artery calcification in uremic ...... by treatment with ibandronate.
@en
type
label
Artery calcification in uremic ...... by treatment with ibandronate.
@en
prefLabel
Artery calcification in uremic ...... by treatment with ibandronate.
@en
P2093
P356
P1433
P1476
Artery calcification in uremic ...... by treatment with ibandronate.
@en
P2093
A M Roublick
M K Williamson
P2888
P304
P356
10.1038/SJ.KI.5001841
P407
P577
2006-09-06T00:00:00Z
P5875
P6179
1011697761